Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Dr Javed Butler Highlights Goals, Baseline Patient Characteristics in EMPACT-MI Trial
August 25th 2023With nearly a third of patients post-myocardial infarction (MI) developing heart failure, prevention is very important, said Javed Butler, MD, MPH, MBA, professor of medicine at University of Mississippi, president of the Baylor Scott & White Research Institute.
Read More
Sneak Peek at ESC Congress 2023 With Dr Stephen Greene
August 23rd 2023Attendees should look out for results from the STEP HFpEF program and HEART-FID trial at the European Society of Cardiology (ESC) Congress 2023, said Stephen Greene, MD, Duke University Medical Center and the Duke Clinical Research Institute.
Read More
As Incoming CEO, Dr Crystal Denlinger Highlights NCCN Guidelines, Challenges, and Treatment Access
August 23rd 2023Crystal Denlinger, MD, FACP, incoming CEO of the National Comprehensive Cancer Network (NCCN), talks about the organization’s challenges and solutions to keeping up with the ever-changing oncology landscape and improving patient access to guideline-recommended treatments.
Read More
Dr John McMurray: ESC Congress 2023 Has Something for Everyone
August 22nd 2023Ahead of the European Society of Cardiology (ESC) Congress 2023, John McMurray, MD, FRCP, FESC, professor of medical cardiology at the University of Glasgow, previews some themes and important topics that will be discussed at the meeting.
Read More
E-Cigarette Use Among Adults With CVD Increased During COVID-19 After Years of Decline
August 17th 2023The decrease in e-cigarette use between 2014 and 2019 may be linked to improved education on the harms of the devices, while the increase in 2019 could be attributed to worsened psychological burden during the COVID-19 pandemic.
Read More
Experts Call for Health System Action to Reduce Hypoglycemia Risk in Older Adults With Diabetes
August 10th 2023According to one panelist, the leading causes of hypoglycemia in older adults are insufficient nutrition and taking the wrong dose or type of insulin, both of which can be addressed at the patient and system level.
Read More
Exercise May Reduce Chemotherapy-Induced Peripheral Neuropathy Symptoms in Women With Ovarian Cancer
August 9th 2023While there is currently no effective treatment for chemotherapy-induced peripheral neuropathy, one of the most common and severe adverse effects for patients who have undergone chemotherapy for ovarian cancer, a 6-month aerobic exercise intervention significantly improved symptoms.
Read More
Certain Fertility Treatments Do Not Increase CVD Risk for Mothers, Study Says
August 9th 2023New research shows that in vitro fertilization with or without intracytoplasmic sperm injection and the use of fresh or frozen embryo transfers were not associated with an increased risk of cardiovascular disease (CVD) for the mother.
Read More
Study Finds Neurocutaneous Syndromes Increase Childhood Cancer Risk
August 5th 2023Using data from the Swedish National Medical Birth Register, researchers found that different neurocutaneous syndromes are associated with increased risk of childhood cancer, especially central nervous system tumors.
Read More
Niraparib Maintenance Therapy Improves PFS by 55% in Advanced Ovarian Cancer
August 2nd 2023Results of the phase 3 PRIME study showed that treatment with niraparib with an individualized starting dose significantly extended progression-free survival (PFS) and reduced the risk of disease progression or death by 55% compared with placebo.
Read More
Dr Ghassan Abou-Alfa Expands on HIMALAYA Phase 3 Results, Methods
July 29th 2023Ghassan Abou-Alfa, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, expands on findings that durvalumab plus tremelimumab demonstrated an overall survival benefit at 4 years for certain patients with unresectable hepatocellular carcinoma.
Read More
SGLT2is Reduce Recurrent Gout Flare More Than DPP-4is in Patients With Diabetes, Study Says
July 27th 2023Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2is) was associated with a 34% lower rate of recurrent gout flare compared with initiation of dipeptidyl peptidase 4 inhibitors (DPP-4is).
Read More
Daily Pitavastatin Reduces Cardiovascular Risk in People With HIV
July 26th 2023Among people living with HIV receiving antiretroviral therapy, those taking 4-mg pitavastatin daily were 35% less likely than those taking placebo to experience a major cardiovascular event over 5 years of follow-up.
Read More
Cell Protein GRP78 Affects Cancer Cell Spread, USC Study Reveals
July 25th 2023New research suggests that when cancer cells are under stress, cellular chaperone protein GRP78 alters its behavior and migrates to the cell's nucleus, where it modifies gene activities and allows cancer cells to become more mobile and invasive.
Read More
Concentrated Exercise Reduces Cardiovascular Risk Similarly to Distributed Exercise
July 18th 2023Research suggests that intense physical activity concentrated within 1-2 days and activity more evenly distributed activity across several days are associated with similarly lower risk of cardiovascular outcomes.
Read More